iSCLife777

iSCLife777 is an umbilical cord-derived hepatic progenitor cell therapy developed by Sclnow Biotechnology for organ reconstruction in patients with liver diseases, such as liver fibrosis and cirrhosis. The treatment utilizes pluripotent stem cells that are differentiated into hepatic progenitor cells to facilitate the regeneration and repair of damaged liver tissue. It is part of the company's iSCLife platform, which focuses on cognate cell therapies for various degenerative and inflammatory conditions. The therapy aims to rebuild functional liver tissue by leveraging the regenerative potential of stem cells, potentially offering a solution for end-stage liver diseases where organ transplantation might otherwise be required.

Brand names

iSCLife777iSCLife-777iSCLife 777SCLnow Organ Reconstruction

Other names

Hepatic Progenitor CellsiSCLife6 D759389 Cognate-Hepatic Progenitor CellsiSCLife-6 D759389 Cognate-Hepatic Progenitor CellsiSCLife 6 D759389 Cognate-Hepatic Progenitor Cells